AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Veeva Systems Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Cardlytics, Inc. (CDLX) â€� Form 4 insider transaction: Chief Legal & Privacy Officer Nicholas Hollmeyer reported the vesting of three restricted-stock-unit (RSU) tranches on 01-Jul-2025, converting a total of 12,788 shares of CDLX common stock. On 02-Jul-2025 he sold 5,271 shares at a weighted-average price of $1.7826 per share. According to the filing, the sale was executed solely to satisfy tax-withholding obligations generated by the RSU delivery.

Following the transactions, Hollmeyer’s direct ownership stands at 109,636 common shares. He also retains 39,945 unvested RSUs across three awards that continue to vest quarterly through 01-Apr-2026. No other insider relationships or indirect holdings were disclosed.

The activity represents a routine equity compensation event rather than a discretionary sale. The net effect is a modest increase in the executive’s equity exposure (shares acquired minus shares sold equals +7,517). Given CDLX’s low absolute share price, the dollar value of the tax-sale (~$9.4 k) is immaterial to the company and is unlikely to influence the investment thesis.

Cardlytics, Inc. (CDLX) � Transazione interna Form 4: Il Chief Legal & Privacy Officer Nicholas Hollmeyer ha segnalato il vesting di tre tranche di unità azionarie vincolate (RSU) il 01-lug-2025, convertendo un totale di 12.788 azioni ordinarie CDLX. Il 02-lug-2025 ha venduto 5.271 azioni ad un prezzo medio ponderato di $1,7826 per azione. Secondo il documento, la vendita è stata effettuata esclusivamente per soddisfare gli obblighi fiscali derivanti dalla consegna delle RSU.

Dopo queste operazioni, la proprietà diretta di Hollmeyer ammonta a 109.636 azioni ordinarie. Mantiene inoltre 39.945 RSU non maturate distribuite su tre premi che continueranno a maturare trimestralmente fino al 01-apr-2026. Non sono state dichiarate altre relazioni interne o partecipazioni indirette.

L’attività rappresenta un evento di compensazione azionaria di routine piuttosto che una vendita discrezionale. L’effetto netto è un modesto incremento dell’esposizione azionaria dell’esecutivo (azioni acquisite meno azioni vendute pari a +7.517). Considerando il basso prezzo assoluto delle azioni CDLX, il valore in dollari della vendita per tasse (~9,4 mila $) è irrilevante per la società e difficilmente influenzerà la tesi d’investimento.

Cardlytics, Inc. (CDLX) � Transacción interna Formulario 4: El Director Legal y de Privacidad Nicholas Hollmeyer reportó la consolidación de tres tramos de unidades de acciones restringidas (RSU) el 01-jul-2025, convirtiendo un total de 12,788 acciones comunes de CDLX. El 02-jul-2025 vendió 5,271 acciones a un precio promedio ponderado de $1.7826 por acción. Según el informe, la venta se realizó únicamente para cumplir con las obligaciones fiscales derivadas de la entrega de las RSU.

Tras las transacciones, la propiedad directa de Hollmeyer es de 109,636 acciones comunes. También conserva 39,945 RSU no consolidadas en tres premios que continúan consolidándose trimestralmente hasta el 01-abr-2026. No se divulgaron otras relaciones internas ni participaciones indirectas.

La actividad representa un evento rutinario de compensación en acciones y no una venta discrecional. El efecto neto es un aumento modesto en la exposición accionaria del ejecutivo (acciones adquiridas menos acciones vendidas equivalen a +7,517). Dado el bajo precio absoluto de las acciones de CDLX, el valor en dólares de la venta para impuestos (~$9.4 mil) es insignificante para la empresa y probablemente no influirá en la tesis de inversión.

Cardlytics, Inc. (CDLX) â€� Form 4 ë‚´ë¶€ìž� 거래: 최고 법률 ë°� ê°œì¸ì •ë³´ ì±…ìž„ìž� Nicholas Hollmeyerê°€ 2025ë…� 7ì›� 1ì¼ì— ì„� ê°œì˜ ì œí•œì£¼ì‹ë‹¨ìœ„(RSU) 트랜치가 베스팅ë˜ì–� ì´� 12,788ì£�ì� CDLX 보통주로 전환ë˜ì—ˆìŒì„ 보고했습니다. 2025ë…� 7ì›� 2ì¼ì—ëŠ� 주당 $1.7826ì� 가중í‰ê·� 가격으ë¡� 5,271ì£�ë¥� 매ë„했습니다. ì‹ ê³ ì„œì— ë”°ë¥´ë©�, ì� 매ë„ëŠ� RSU ì§€ê¸‰ì— ë”°ë¥¸ 세금 ì›ì²œì§•수 ì˜ë¬´ë¥� 충족하기 위해서만 ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�.

거래 í›� Hollmeyerì� ì§ì ‘ 보유 주ì‹ì€ 109,636ì£�입니ë‹�. ë˜í•œ 2026ë…� 4ì›� 1ì¼ê¹Œì§€ 분기별로 베스팅ë˜ëŠ� ì„� ê±´ì˜ ë¯¸ë² ìŠ¤íŒ… RSU 39,945ì£�ë� 보유하고 있습니다. 다른 ë‚´ë¶€ìž� 관계나 ê°„ì ‘ 보유ëŠ� 공개ë˜ì§€ 않았습니ë‹�.

ì´ë²ˆ 활ë™ì€ ìž„ì˜ ë§¤ë„ê°€ 아닌 ì¼ìƒì ì¸ ì£¼ì‹ ë³´ìƒ í–‰ì‚¬ì—� 해당합니ë‹�. 순효과는 ê²½ì˜ì§„ì˜ ì£¼ì‹ ë…¸ì¶œì� 약간 ì¦ê°€í•� 것으ë¡� (ì·¨ë“ ì£¼ì‹ ìˆ˜ì—ì„� ë§¤ë„ ì£¼ì‹ ìˆ˜ë¥¼ 뺀 ê°’ì€ +7,517) 나타났습니다. CDLXì� ë‚®ì€ ì ˆëŒ€ 주가ë¥� ê³ ë ¤í•� ë•�, 세금 매ë„ì•�(ì•� 9,400달러)ì€ íšŒì‚¬ì—� 미미í•� ì˜í–¥ë§� 미치ë©� íˆ¬ìž ë…¼ë¦¬ì—� í� ì˜í–¥ì� 주지 ì•Šì„ ê²ƒìž…ë‹ˆë‹¤.

Cardlytics, Inc. (CDLX) � Transaction d’initié Formulaire 4 : Le Chief Legal & Privacy Officer Nicholas Hollmeyer a déclaré le vesting de trois tranches d’unités d’actions restreintes (RSU) le 01-juil-2025, convertissant un total de 12 788 actions ordinaires CDLX. Le 02-juil-2025, il a vendu 5 271 actions à un prix moyen pondéré de 1,7826 $ par action. Selon le dépôt, la vente a été réalisée uniquement pour satisfaire les obligations fiscales liées à la livraison des RSU.

Après ces opérations, la détention directe de Hollmeyer s’élève à 109 636 actions ordinaires. Il conserve également 39 945 RSU non acquises réparties sur trois attributions qui continuent de se libérer trimestriellement jusqu’au 01-avr-2026. Aucune autre relation d’initié ou détention indirecte n’a été divulguée.

Cette activité représente un événement de rémunération en actions de routine plutôt qu’une vente discrétionnaire. L’effet net est une augmentation modérée de l’exposition en actions de l’exécutif (actions acquises moins actions vendues égale +7 517). Compte tenu du faible prix absolu de l’action CDLX, la valeur en dollars de la vente pour impôt (~9,4 k$) est insignifiante pour la société et est peu susceptible d’influencer la thèse d’investissement.

Cardlytics, Inc. (CDLX) � Form 4 Insider-Transaktion: Chief Legal & Privacy Officer Nicholas Hollmeyer meldete am 01. Juli 2025 die Vesting von drei Tranchen von Restricted Stock Units (RSUs), wodurch insgesamt 12.788 Aktien von CDLX-Stammaktien umgewandelt wurden. Am 02. Juli 2025 verkaufte er 5.271 Aktien zu einem gewichteten Durchschnittspreis von $1,7826 pro Aktie. Laut der Meldung erfolgte der Verkauf ausschließlich zur Erfüllung der Steuerabzugsverpflichtungen, die durch die RSU-Zuteilung entstanden sind.

Nach den Transaktionen hält Hollmeyer direkt 109.636 Stammaktien. Zudem besitzt er 39.945 unverfallbare RSUs aus drei Auszeichnungen, die weiterhin vierteljährlich bis zum 01. April 2026 vesten. Weitere Insider-Beziehungen oder indirekte Beteiligungen wurden nicht offengelegt.

Die Aktivität stellt ein routinemäßiges Aktienvergütungsereignis dar und keine diskretionäre Veräußerung. Der Nettoeffekt ist ein moderater Zuwachs der Aktienexponierung des Executives (erworbene Aktien minus verkaufte Aktien = +7.517). Angesichts des niedrigen absoluten Aktienkurses von CDLX ist der Dollarwert des Steuerverkaufs (~9,4 Tsd. $) für das Unternehmen unerheblich und wird die Investmentthese wahrscheinlich nicht beeinflussen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU vesting; small tax-related sale, immaterial to valuation.

The filing documents standard quarterly RSU vesting for a senior officer. Although 5,271 shares were sold, the purpose was tax withholding, not discretionary profit-taking, limiting any negative signal. Net share ownership increased, and the remaining 39.9 k RSUs sustain management’s long-term incentive alignment. With an estimated sale value below $10 k and no change to executive roles or corporate strategy, I view the disclosure as neutral from a market-impact perspective.

Cardlytics, Inc. (CDLX) � Transazione interna Form 4: Il Chief Legal & Privacy Officer Nicholas Hollmeyer ha segnalato il vesting di tre tranche di unità azionarie vincolate (RSU) il 01-lug-2025, convertendo un totale di 12.788 azioni ordinarie CDLX. Il 02-lug-2025 ha venduto 5.271 azioni ad un prezzo medio ponderato di $1,7826 per azione. Secondo il documento, la vendita è stata effettuata esclusivamente per soddisfare gli obblighi fiscali derivanti dalla consegna delle RSU.

Dopo queste operazioni, la proprietà diretta di Hollmeyer ammonta a 109.636 azioni ordinarie. Mantiene inoltre 39.945 RSU non maturate distribuite su tre premi che continueranno a maturare trimestralmente fino al 01-apr-2026. Non sono state dichiarate altre relazioni interne o partecipazioni indirette.

L’attività rappresenta un evento di compensazione azionaria di routine piuttosto che una vendita discrezionale. L’effetto netto è un modesto incremento dell’esposizione azionaria dell’esecutivo (azioni acquisite meno azioni vendute pari a +7.517). Considerando il basso prezzo assoluto delle azioni CDLX, il valore in dollari della vendita per tasse (~9,4 mila $) è irrilevante per la società e difficilmente influenzerà la tesi d’investimento.

Cardlytics, Inc. (CDLX) � Transacción interna Formulario 4: El Director Legal y de Privacidad Nicholas Hollmeyer reportó la consolidación de tres tramos de unidades de acciones restringidas (RSU) el 01-jul-2025, convirtiendo un total de 12,788 acciones comunes de CDLX. El 02-jul-2025 vendió 5,271 acciones a un precio promedio ponderado de $1.7826 por acción. Según el informe, la venta se realizó únicamente para cumplir con las obligaciones fiscales derivadas de la entrega de las RSU.

Tras las transacciones, la propiedad directa de Hollmeyer es de 109,636 acciones comunes. También conserva 39,945 RSU no consolidadas en tres premios que continúan consolidándose trimestralmente hasta el 01-abr-2026. No se divulgaron otras relaciones internas ni participaciones indirectas.

La actividad representa un evento rutinario de compensación en acciones y no una venta discrecional. El efecto neto es un aumento modesto en la exposición accionaria del ejecutivo (acciones adquiridas menos acciones vendidas equivalen a +7,517). Dado el bajo precio absoluto de las acciones de CDLX, el valor en dólares de la venta para impuestos (~$9.4 mil) es insignificante para la empresa y probablemente no influirá en la tesis de inversión.

Cardlytics, Inc. (CDLX) â€� Form 4 ë‚´ë¶€ìž� 거래: 최고 법률 ë°� ê°œì¸ì •ë³´ ì±…ìž„ìž� Nicholas Hollmeyerê°€ 2025ë…� 7ì›� 1ì¼ì— ì„� ê°œì˜ ì œí•œì£¼ì‹ë‹¨ìœ„(RSU) 트랜치가 베스팅ë˜ì–� ì´� 12,788ì£�ì� CDLX 보통주로 전환ë˜ì—ˆìŒì„ 보고했습니다. 2025ë…� 7ì›� 2ì¼ì—ëŠ� 주당 $1.7826ì� 가중í‰ê·� 가격으ë¡� 5,271ì£�ë¥� 매ë„했습니다. ì‹ ê³ ì„œì— ë”°ë¥´ë©�, ì� 매ë„ëŠ� RSU ì§€ê¸‰ì— ë”°ë¥¸ 세금 ì›ì²œì§•수 ì˜ë¬´ë¥� 충족하기 위해서만 ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�.

거래 í›� Hollmeyerì� ì§ì ‘ 보유 주ì‹ì€ 109,636ì£�입니ë‹�. ë˜í•œ 2026ë…� 4ì›� 1ì¼ê¹Œì§€ 분기별로 베스팅ë˜ëŠ� ì„� ê±´ì˜ ë¯¸ë² ìŠ¤íŒ… RSU 39,945ì£�ë� 보유하고 있습니다. 다른 ë‚´ë¶€ìž� 관계나 ê°„ì ‘ 보유ëŠ� 공개ë˜ì§€ 않았습니ë‹�.

ì´ë²ˆ 활ë™ì€ ìž„ì˜ ë§¤ë„ê°€ 아닌 ì¼ìƒì ì¸ ì£¼ì‹ ë³´ìƒ í–‰ì‚¬ì—� 해당합니ë‹�. 순효과는 ê²½ì˜ì§„ì˜ ì£¼ì‹ ë…¸ì¶œì� 약간 ì¦ê°€í•� 것으ë¡� (ì·¨ë“ ì£¼ì‹ ìˆ˜ì—ì„� ë§¤ë„ ì£¼ì‹ ìˆ˜ë¥¼ 뺀 ê°’ì€ +7,517) 나타났습니다. CDLXì� ë‚®ì€ ì ˆëŒ€ 주가ë¥� ê³ ë ¤í•� ë•�, 세금 매ë„ì•�(ì•� 9,400달러)ì€ íšŒì‚¬ì—� 미미í•� ì˜í–¥ë§� 미치ë©� íˆ¬ìž ë…¼ë¦¬ì—� í� ì˜í–¥ì� 주지 ì•Šì„ ê²ƒìž…ë‹ˆë‹¤.

Cardlytics, Inc. (CDLX) � Transaction d’initié Formulaire 4 : Le Chief Legal & Privacy Officer Nicholas Hollmeyer a déclaré le vesting de trois tranches d’unités d’actions restreintes (RSU) le 01-juil-2025, convertissant un total de 12 788 actions ordinaires CDLX. Le 02-juil-2025, il a vendu 5 271 actions à un prix moyen pondéré de 1,7826 $ par action. Selon le dépôt, la vente a été réalisée uniquement pour satisfaire les obligations fiscales liées à la livraison des RSU.

Après ces opérations, la détention directe de Hollmeyer s’élève à 109 636 actions ordinaires. Il conserve également 39 945 RSU non acquises réparties sur trois attributions qui continuent de se libérer trimestriellement jusqu’au 01-avr-2026. Aucune autre relation d’initié ou détention indirecte n’a été divulguée.

Cette activité représente un événement de rémunération en actions de routine plutôt qu’une vente discrétionnaire. L’effet net est une augmentation modérée de l’exposition en actions de l’exécutif (actions acquises moins actions vendues égale +7 517). Compte tenu du faible prix absolu de l’action CDLX, la valeur en dollars de la vente pour impôt (~9,4 k$) est insignifiante pour la société et est peu susceptible d’influencer la thèse d’investissement.

Cardlytics, Inc. (CDLX) � Form 4 Insider-Transaktion: Chief Legal & Privacy Officer Nicholas Hollmeyer meldete am 01. Juli 2025 die Vesting von drei Tranchen von Restricted Stock Units (RSUs), wodurch insgesamt 12.788 Aktien von CDLX-Stammaktien umgewandelt wurden. Am 02. Juli 2025 verkaufte er 5.271 Aktien zu einem gewichteten Durchschnittspreis von $1,7826 pro Aktie. Laut der Meldung erfolgte der Verkauf ausschließlich zur Erfüllung der Steuerabzugsverpflichtungen, die durch die RSU-Zuteilung entstanden sind.

Nach den Transaktionen hält Hollmeyer direkt 109.636 Stammaktien. Zudem besitzt er 39.945 unverfallbare RSUs aus drei Auszeichnungen, die weiterhin vierteljährlich bis zum 01. April 2026 vesten. Weitere Insider-Beziehungen oder indirekte Beteiligungen wurden nicht offengelegt.

Die Aktivität stellt ein routinemäßiges Aktienvergütungsereignis dar und keine diskretionäre Veräußerung. Der Nettoeffekt ist ein moderater Zuwachs der Aktienexponierung des Executives (erworbene Aktien minus verkaufte Aktien = +7.517). Angesichts des niedrigen absoluten Aktienkurses von CDLX ist der Dollarwert des Steuerverkaufs (~9,4 Tsd. $) für das Unternehmen unerheblich und wird die Investmentthese wahrscheinlich nicht beeinflussen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schwenger Thomas D.

(Last) (First) (Middle)
C/O VEEVA SYSTEMS INC.
4280 HACIENDA DRIVE

(Street)
PLEASANTON CA 94588

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VEEVA SYSTEMS INC [ VEEV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Pres. & Chief Customer Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/01/2025(1) M 2,043 A $0(2) 26,782 D
Class A Common Stock 07/01/2025 F(3) 808(3) D $282.9 25,974 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) 07/01/2025(1) M 2,043 (4) (4) Class A Common Stock 2,043 $0 6,128 D
Explanation of Responses:
1. Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.
2. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.
3. Represents shares that have been withheld by the Issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of vested restricted stock units and not a market transaction. Transaction exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated under the Act.
4. The RSUs were granted under the Issuer's Amended & Restated 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year with 25% vesting on July 1, 2025, and 25% of the RSUs vesting on a quarterly basis thereafter, subject to continued service to the Issuer by the Reporting Person.
Remarks:
/s/ Liang Dong, attorney-in-fact 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CDLX shares did Nicholas Hollmeyer acquire through RSU vesting?

12,788 shares vested and converted to common stock on 01-Jul-2025.

What was the sale price for the CDLX shares sold on 02-Jul-2025?

The weighted-average sale price was $1.7826 per share, within a $1.66�$1.8451 range.

How many CDLX shares does the insider own after the transactions?

Direct ownership is 109,636 common shares plus 39,945 unvested RSUs.

Why were shares sold by the insider?

All shares sold were solely to cover tax-withholding obligations arising from RSU vesting.

Do the transactions indicate a change in insider sentiment toward Cardlytics (CDLX)?

The filing appears routine; net ownership increased, so it does not signal a bearish outlook.
Veeva Sys Inc

NYSE:VEEV

VEEV Rankings

VEEV Latest News

VEEV Latest SEC Filings

VEEV Stock Data

45.67B
149.44M
8.92%
85.05%
2.46%
Health Information Services
Services-prepackaged Software
United States
PLEASANTON